Mow Jonathan P
Related Filers (1)
Ownership (19)
4
Tuesday, 5/24/2022
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 2/28/2022
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 11/23/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 11/3/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 8/30/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 5/24/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 2/9/2021
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 11/23/2020
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 8/24/2020
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 2/14/2020
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 9/10/2019
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 5/21/2019
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Friday, 3/1/2019
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Monday, 12/17/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4/A
Thursday, 12/13/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Tuesday, 12/11/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
4
Wednesday, 10/24/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities
3
Wednesday, 10/17/2018
PhaseBio Pharmaceuticals Inc: Initial statement of beneficial ownership of securities
4
Wednesday, 10/17/2018
PhaseBio Pharmaceuticals Inc: Statement of changes in beneficial ownership of securities